CRESTONE: A Phase 2 Study of Seribantumab in Adult Patients with Neuregulin-1 (NRG1) Fusion Positive Locally Advanced or Metastatic Solid Tumors
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Treatment
Locations
University of Colorado Hospital
Study ID
Protocol Number: 20-1736
More information available at ClinicalTrials.gov: NCT04383210
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers